46 research outputs found
World Bank Lending and Financial Sector Development
No full textA new database of World Bank loans to support financial sector development is used to investigate whether countries that received such loans experienced more rapid growth on standard indicators of financial development than countries that did not. Self-selection is accounted for with treatment-effects regressions. The results indicate that borrowing countries had significantly more rapid growth in M2/GDP than nonborrowers and swifter reductions in interest rate spreads and cash holdings (as a share of M2). Borrowers also had higher private credit growth rates than nonborrowers in some treatment-effects regressions but not in standard panel regressions with fixed country effects. On the whole, the results indicate some significant advantages in financial development for borrowers over nonborrowers. Copyright The Author 2008. Published by Oxford University Press on behalf of the International Bank for Reconstruction and Development / the world bank . All rights reserved. For permissions, please e-mail: [email protected], Oxford University Press.
Critical effect of timing of abciximab bolus relative to first balloon inflation in primary angioplasty. The RAPPORT trial
No full textAbciximab improves outcomes in patients of all ages: Pooled analysis of 4 phase 3 trials
No full textProvisional stenting improves outcome of primary angioplasty independently of the use of Abciximab. The RAPPORT trial
No full textPCV35 PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
No full textCan Self-affirmation Encourage HIV-Prevention? Evidence from Female Sex Workers in Senegal.
No full textWe test an intervention aiming to increase condom usage and HIV testing in a stigmatized population at high risk of contracting HIV: female sex workers (FSWs) in Senegal. Some sex work is legal in Senegal, and condoms and HIV tests are freely available to registered FSWs-but FSWs may be reluctant to get tested and use condoms, in part because doing so would entail acknowledging their risk of contracting HIV and potentially expose them to stigma. Drawing on self-affirmation theory, we hypothesized that reflecting on a source of personal pride would help participants acknowledge their risk of HIV, intend to use condoms more frequently, and take an HIV test. Prior research suggests that similar self-affirmation interventions can help people acknowledge their health risks and improve their health behavior, especially when paired with information about effectively managing their health (i.e., self-efficacy information). However, such interventions have primarily been tested in the United States and United Kingdom, and their generalizability outside of these contexts is unclear. Our high-powered experiment randomly assigned participants (N = 592 FSWs; N = 563 in the final analysis) to a self-affirmation condition or a control condition and measured their risk perceptions, whether they took condoms offered to them, and whether (after randomly receiving or not receiving self-efficacy information) they took an HIV test. We found no support for any of our hypotheses. We discuss several explanations for these null results based on the stigma attached to sex work and HIV, cross-cultural generalizability of self-affirmation interventions, and robustness of previous findings. [Abstract copyright: © 2023. The Author(s).
Tadalafil does not affect time to ischemia during exercise stress testing in patients with coronary artery disease
No full textEffect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty
No full textTimely reperfusion therapy in acute myocardial infarction limits infarct size and improves survival.(1) Compared with fibrinolytic therapy, primary angioplasty achieves Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow in a higher proportion of patients and is associated with improved early outcome.(2) Despite superior ability to relieve epicardial artery stenosis, mechanical revascularization is frequently associated with embolization of plaque and platelet thrombus to the distal capillary bed, which may result in a no-reflow phenomenon similar to that observed with fibrinolysis.(3) Because platelet IIb/IIIa receptor blockade with abciximab has been shown to reduce the incidence of acute ischemic events after coronary angioplasty, the combination of primary angioplasty and platelet integrin inhibition has been tested in the ReoPro And Primary PTCA Organization and Randomized Trial (RAPPORT).(4) In patients undergoing angioplasty and receiving abciximab, the 7-day incidence of reinfarction and urgent reintervention was reduced by 76% (p = 0.06) and 79% (p = 0.008), respectively, when compared with placebo. It is not known whether abciximab affected infarct size or the speed of reperfusion WP investigated whether the platelet inhibition afforded by abciximab altered the pattern of reperfusion in patients undergoing primary angioplasty with respect to peak creatine kinase (CK) release, infarct size expressed as area-under-the-curve (AUC), and time-to-peak CK
Can abciximab prevent neointimal proliferation in Palmaz-Schatz stents? The final ERASER results
No full text
